{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:16:55Z","timestamp":1788553015662,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:00:00Z","timestamp":1786233600000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA021765"],"award-info":[{"award-number":["P30 CA021765"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01\\u2002AI058145"],"award-info":[{"award-number":["R01\\u2002AI058145"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cmi.2026.07.047","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:19:03Z","timestamp":1785885543000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mutations in MRR1 that confer fluconazole resistance in Candida parapsilosis and Candida albicans confer cross-resistance to manogepix"],"prefix":"10.1016","author":[{"given":"Katherine S.","family":"Barker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoja P.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Morschh\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan P.","family":"Wiederhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. David","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2026.07.047_bib1","doi-asserted-by":"crossref","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: Human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cmi.2026.07.047_bib2","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/ofid\/ofy358","article-title":"Twenty years of the SENTRY antifungal surveillance program: Results for Candida species from 1997-2016","volume":"6","author":"Pfaller","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2026.07.047_bib3","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/jac\/dkx444","article-title":"Changes in the epidemiological landscape of invasive candidiasis","volume":"73","author":"Lamoth","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2026.07.047_bib4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s00134-022-06944-2","article-title":"Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: The EUROBACT-2 international cohort study","volume":"49","author":"Tabah","year":"2023","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2026.07.047_bib5","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1128\/JCM.01283-12","article-title":"Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011","volume":"50","author":"Lockhart","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2026.07.047_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12539","article-title":"Global trends in the distribution of Candida species causing candidemia","volume":"20","author":"Guinea","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2026.07.047_bib7","doi-asserted-by":"crossref","first-page":"e00111","DOI":"10.1128\/CMR.00111-18","article-title":"Candida parapsilosis: From genes to the bedside","volume":"32","author":"T\u00f3th","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2026.07.047_bib8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/cid\/civ1194","article-title":"Executive summary: Clinical practice guideline for the Management of Candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.07.047_bib9","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","article-title":"Global guideline for the diagnosis and management of candidiasis: An initiative of the ECMM in cooperation with ISHAM and ASM","volume":"25","author":"Cornely","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2026.07.047_bib10","doi-asserted-by":"crossref","first-page":"S612","DOI":"10.1093\/cid\/civ791","article-title":"Echinocandin resistance in Candida","volume":"61","author":"Perlin","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.07.047_bib11","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1128\/AAC.00262-08","article-title":"A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility","volume":"52","author":"Garcia-Effron","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.07.047_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/jof7040259","article-title":"Environmental clonal spread of azole-resistant Candida parapsilosis with Erg11-Y132F mutation causing a large candidemia outbreak in a Brazilian cancer referral center","volume":"7","author":"Thomaz","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.cmi.2026.07.047_bib13","first-page":"1","article-title":"Clinical impact of fluconazole-resistant Candida parapsilosis: A narrative review","volume":"11","author":"Bartalucci","year":"2025","journal-title":"Future Microbiol."},{"key":"10.1016\/j.cmi.2026.07.047_bib14","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/cid\/ciab1070","article-title":"Investigational antifungal agents for invasive mycoses: A clinical perspective","volume":"73","author":"Lamoth","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.07.047_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01225-18","article-title":"APX001A in vitro activity against contemporary blood isolates and Candida auris determined by the EUCAST reference method","volume":"62","author":"Arendrup","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.07.047_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00429-20","article-title":"Manogepix (APX001A) displays potent in vitro activity against human pathogenic yeast, but with an unexpected correlation to fluconazole MICs","volume":"64","author":"Arendrup","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.07.047_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00261-20","article-title":"Enhanced efflux pump expression in Candida mutants results in decreased manogepix susceptibility","volume":"64","author":"Liston","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.07.047_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01508-24","article-title":"TAC1b mutation in Candida auris decreases manogepix susceptibility owing to increased CDR1 expression","volume":"69","author":"Hirayama","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.07.047_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00680-25","article-title":"Mutations in transcription factors that confer fluconazole resistance also confer reduced susceptibility to manogepix in Candida auris (Candidozyma auris), Candida albicans, Candida parapsilosis, and Candida glabrata (Nakaseomyces glabratus)","volume":"69","author":"Barker","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.07.047_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0030164","article-title":"The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans","volume":"3","author":"Morschh\u00e4user","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cmi.2026.07.047_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00289-22","article-title":"Candida parapsilosis Mdr1B and Cdr1B are drivers of Mrr1-mediated clinical fluconazole resistance","volume":"66","author":"Doorley","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.07.047_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00328721","article-title":"Isolation of the Candida albicans gene for orotidine-5\u2019-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations","volume":"198","author":"Gillum","year":"1984","journal-title":"Mol Gen Genet"},{"key":"10.1016\/j.cmi.2026.07.047_bib23","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1128\/AAC.42.12.3065","article-title":"Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains","volume":"42","author":"Franz","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.07.047_bib24","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1046\/j.1365-2958.2000.01899.x","article-title":"Targeted gene disruption in Candida albicans wild-type strains: The role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates","volume":"36","author":"Wirsching","year":"2000","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.cmi.2026.07.047_bib25","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1128\/EC.05100-11","article-title":"Functional dissection of a Candida albicans zinc cluster transcription factor, the multidrug resistance regulator Mrr1","volume":"10","author":"Schubert","year":"2011","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.cmi.2026.07.047_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006655","article-title":"An acquired mechanism of antifungal drug resistance simultaneously enables Candida albicans to escape from intrinsic host defenses","volume":"13","author":"Hampe","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cmi.2026.07.047_bib27","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1128\/AAC.00264-12","article-title":"Inducible and constitutive activation of two polymorphic promoter alleles of the Candida albicans multidrug efflux pump MDR1","volume":"56","author":"Sasse","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.07.047_bib28","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts","year":"2017"},{"key":"10.1016\/j.cmi.2026.07.047_bib29","series-title":"Performance standards for antifungal susceptibility testing of yeasts","year":"2022"},{"key":"10.1016\/j.cmi.2026.07.047_bib30","series-title":"WHO fungal priority pathogens list to guide research, development, and public health action","year":"2022"},{"key":"10.1016\/j.cmi.2026.07.047_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02586-18","article-title":"The evolution of azole resistance in Candida albicans sterol 14\u03b1-demethylase (CYP51) through incremental amino acid substitutions","volume":"63","author":"Warrilow","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.07.047_bib32","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","article-title":"Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species","volume":"7","author":"Whaley","year":"2017","journal-title":"Front Microbiol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26004143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26004143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:02:00Z","timestamp":1788552120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X26004143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":32,"alternative-id":["S1198743X26004143"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2026.07.047","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutations in MRR1 that confer fluconazole resistance in Candida parapsilosis and Candida albicans confer cross-resistance to manogepix","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2026.07.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}